Literature DB >> 28062572

Updates in understanding the role of cyclophilin A in leukocyte chemotaxis.

Farman Ullah Dawar1, Junjie Wu1, Lijuan Zhao1,2, Muhammad Nasir Khan Khattak3,4, Jie Mei5, Li Lin6,2.   

Abstract

Cyclophilin A (CypA), a well-recognized receptor for anti-inflammatory drug cyclosporine A (CsA) is a ubiquitous and multifunctional protein. Beside the diverse intracellular functions, CypA is secreted against inflammatory stimuli, where it activates and attracts leukocytes via CD147 to the stimulus site. Interestingly, it synergizes with other factors to induce leukocyte migration in different animals. However, the silencing and inhibition of CypA or CD147 inhibits leukocytes chemotaxis and inflammation. This review focuses on the advances made in understanding the mechanism of CypA-dependent leukocytes chemotaxis and hence, recognition of this factor as a possible therapeutic target in inflammatory diseases. © Society for Leukocyte Biology.

Entities:  

Keywords:  cyclosporine A; inflammation; migration

Mesh:

Substances:

Year:  2017        PMID: 28062572     DOI: 10.1189/jlb.3RU1116-477R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis.

Authors:  Minghua Lv; Jinlin Miao; Peng Zhao; Xing Luo; Qing Han; Zhenbiao Wu; Kui Zhang; Ping Zhu
Journal:  Clin Rheumatol       Date:  2017-09-25       Impact factor: 2.980

2.  Inhibition of the cyclophilin A-CD147 interaction attenuates right ventricular injury and dysfunction after acute pulmonary embolism in rats.

Authors:  Guangdong Lu; Zhenyu Jia; Qingquan Zu; Jinxing Zhang; Linbo Zhao; Haibin Shi
Journal:  J Biol Chem       Date:  2018-06-18       Impact factor: 5.157

Review 3.  SARS-CoV-2 cell entry beyond the ACE2 receptor.

Authors:  Shamila D Alipoor; Mehdi Mirsaeidi
Journal:  Mol Biol Rep       Date:  2022-06-26       Impact factor: 2.742

4.  Secreted Extracellular Cyclophilin A Is a Novel Mediator of Ventilator-induced Lung Injury.

Authors:  Marissa W Koh; Rhianna F Baldi; Sanooj Soni; Rhodri Handslip; Ying Ying Tan; Kieran P O'Dea; Miroslav Malesevic; Daniel F McAuley; Cecilia M O'Kane; Brijesh V Patel; Masao Takata; Michael R Wilson
Journal:  Am J Respir Crit Care Med       Date:  2021-08-15       Impact factor: 21.405

Review 5.  Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation.

Authors:  Marco Cardone; Masahide Yano; Amy S Rosenberg; Montserrat Puig
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561

6.  A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models.

Authors:  Joseph Kuo; Michael Bobardt; Udayan Chatterji; Patrick R Mayo; Daniel J Trepanier; Robert T Foster; Philippe Gallay; Daren R Ure
Journal:  J Pharmacol Exp Ther       Date:  2019-08-12       Impact factor: 4.030

Review 7.  ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.

Authors:  Natalia Zamorano Cuervo; Nathalie Grandvaux
Journal:  Elife       Date:  2020-11-09       Impact factor: 8.140

Review 8.  Advances in immunotherapy for COVID-19: A comprehensive review.

Authors:  Masoomeh Masoomikarimi; Behzad Garmabi; Javad Alizadeh; Erfan Kazemi; Amirhossein Azari Jafari; Seyyedmohammadsadeq Mirmoeeni; Motahareh Dargahi; Niloofar Taheri; Reza Jafari
Journal:  Int Immunopharmacol       Date:  2021-01-22       Impact factor: 5.714

Review 9.  A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19).

Authors:  Maryam Rameshrad; Majid Ghafoori; Amir Hooshang Mohammadpour; Mohammad Javad Dehghan Nayeri; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-05-19       Impact factor: 3.000

10.  Genome-Wide Analysis of Cyclophilin Proteins in 21 Oomycetes.

Authors:  Yan Zhang; Kyle Fletcher; Rongkui Han; Richard Michelmore; Ruiwu Yang
Journal:  Pathogens       Date:  2019-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.